Differential Composition of Vaginal Microbiome Is Associated With Successful Intrauterine Insemination in Couples With Idiopathic Infertility Original paper

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

June 26, 2025

  • Women’s Health
    Women’s Health

    Women’s health, a vital aspect of medical science, encompasses various conditions unique to women’s physiological makeup. Historically, women were often excluded from clinical research, leading to a gap in understanding the intricacies of women’s health needs. However, recent advancements have highlighted the significant role that the microbiome plays in these conditions, offering new insights and potential therapies. MicrobiomeSignatures.com is at the forefront of exploring the microbiome signature of each of these conditions to unravel the etiology of these diseases and develop targeted microbiome therapies.

  • Infertility
    Infertility

    Infertility is the inability to conceive after 12 months of regular, unprotected sex. It affects both men and women and can be due to various physical, hormonal, or genetic factors. Treatments include medication, surgery, assisted reproductive technologies, and lifestyle changes.

  • Female Infertility
    Female Infertility

    Female infertility is a multifactorial condition affecting 10-15% of women of reproductive age, often caused by underlying conditions like Bacterial Vaginosis (BV), PCOS, Endometriosis, and Pelvic Inflammatory Disease (PID). Microbiome-targeted interventions (MBTIs) offer a promising approach to restoring balance, improving fertility outcomes, and addressing root causes.

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

Last Updated: 2025

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Divine Aleru

I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

What was studied?

This study examined the vaginal and seminal microbiomes of couples with idiopathic infertility and their correlation with intrauterine insemination (IUI) outcomes. The researchers sought to determine whether the microbiomes of the vaginal and seminal fluids influence the success rate of IUI. They specifically focused on identifying any differences in the microbiota composition between women with successful and unsuccessful IUI outcomes, particularly in relation to Lactobacillus species, which are considered crucial for maintaining a healthy vaginal environment.

Who was studied?

The study involved 23 couples with idiopathic infertility undergoing their first IUI treatment at the Centro Scienze della Natalità in Milan, Italy. Both female and male partners participated, with vaginal swabs taken from the female participants and seminal fluid samples from the male participants on the day of the IUI procedure. The female participants had a mean age of 33 years, and the male participants were approximately 34 years old. The couples were all Caucasian, and the women underwent a comprehensive clinical evaluation to exclude any other known causes of infertility, such as endometriosis or male factor infertility.

What were the most important findings?

The study found that the vaginal microbiome composition differed significantly between women who achieved pregnancy following IUI and those who did not. Women with successful IUI outcomes had a vaginal microbiome predominantly dominated by Lactobacillus crispatus, which is associated with a healthy and stable vaginal ecosystem. On the other hand, women who experienced IUI failure showed a greater diversity in their vaginal microbiota, including higher levels of Bifidobacterium and other non-Lactobacillus species, indicating a more dysbiotic environment. The presence of Lactobacillus species, especially L. crispatus, was strongly associated with a higher probability of successful pregnancy. Interestingly, no significant differences in the seminal microbiome were observed between men whose partners experienced success or failure in IUI, suggesting that male seminal microbiota might not play as critical a role in IUI success as vaginal microbiota does.

What are the greatest implications of this study?

The findings suggest that the vaginal microbiome, particularly the dominance of Lactobacillus crispatus, could serve as an important biomarker for predicting IUI success in couples with idiopathic infertility. This underscores the potential value of incorporating vaginal microbiome analysis into fertility assessments prior to IUI procedures. Clinicians might consider characterizing the vaginal microbiome in these patients and explore interventions, such as probiotics or other microbiome-targeted therapies, to restore a more optimal microbial balance and improve reproductive outcomes. However, given the study’s relatively small sample size, further research with larger cohorts is necessary to confirm these findings and determine the clinical applicability of microbiome-based interventions.

Infertility

Infertility is the inability to conceive after 12 months of regular, unprotected sex. It affects both men and women and can be due to various physical, hormonal, or genetic factors. Treatments include medication, surgery, assisted reproductive technologies, and lifestyle changes.

Microbiome-Targeted Interventions (MBTIs)

Microbiome Targeted Interventions (MBTIs) are cutting-edge treatments that utilize information from Microbiome Signatures to modulate the microbiome, revolutionizing medicine with unparalleled precision and impact.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.